Page 5 - Veeva Development Cloud News Today

PLEASANTON, Calif., Jan. 20, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that the Lymphoma Academic Research Organization (LYSARC) selected...

This year we were fortunate to have 4,000+ participants for the Veeva R&D and Quality Summit Connect, including 400+ pharma professionals in the Veeva Development Cloud and Vault Platform... | December 15, 2021

VEEV earnings call for the period ending September 30, 2021.

Veeva Announces Fiscal 2022 First Quarter Results Total Revenues of $433.6M, up 29% Year Over Year; Subscription Services Revenues of $341.1M, up 26% Year Over Year News provided by Share this article Share this article PLEASANTON, Calif., May 27, 2021 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2021. "The teams focus on customer success and...

Veeva Development Cloud Streamlining Drug Development Industrywide Unified application suites for clinical, regulatory, quality, and safety eliminate siloes to increase efficiency and improve compliance News provided by Share this article Share this article PLEASANTON, Calif., May 19, 2021 /PRNewswire/ -- A growing number of life sciences companies are adopting Veeva Development Cloud applications from Veeva Systems (NYSE: VEEV) in an industrywide shift to streamline drug development. More than...

Industry leaders come together to connect, learn, and share experiences in advancing drug development BARCELONA, Spain, April 28, 2021 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced

Veeva Systems: More Than 250 Companies Transform Regulatory with Veeva Vault RIM Applications and keep up with changing regulations like IDMP Veeva Systems (NYSE: VEEV) today announced that more than 250 organizations are using Veeva Vault RIM applications for end-to-end regulatory information management. A growing number of emerging biotechs and enterprise companies, including 12 of the top 20 global pharmaceutical companies, are modernizing submission planning, tracking, and publishing to...